Multiple Myeloma, Refractory Clinical Trials in St Louis, Missouri
2 recruitingSt Louis, Missouri
Showing 1–2 of 2 trials
Recruiting
Phase 1
Recombinant Human IL-7 (NT-I7) in Relapsed/Refractory Multiple Myeloma Following BCMA CAR-T Therapy (Cilta-cel)
Multiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma, Refractory
Washington University School of Medicine52 enrolled1 locationNCT07200089
Recruiting
Phase 2
Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Multiple Myeloma in RelapseMultiple Myeloma, Refractory
CellCentric Ltd.100 enrolled20 locationsNCT07096778